Medidata Celebrates World Heart Day
When it comes to fighting Cardiovascular Disease, experience matters.
Medidata Supports World Heart Day
Each year, on September 29th, the heart community comes together for World Heart Day, to raise awareness about the disease and its impact on patients’ lives, and to highlight to the world how to live heart-healthy lives.
CVD is the world’s leading cause of death, responsible for more than 25.5 million fatalities annually and affecting over 520 million people. Medidata’s cloud-based platform enables clinical trials to run smoother, faster, and safer for patients in today’s complex world of precision medicine and has the trial experience, technology and expertise to help Cardiovascular trials. Supporting 168 biopharma and medical device companies in conducting 1,115+ cardiovascular studies with over 1 million patients.
The Adaptable Study, The Largest Decentralized Cardiovascular Trial to Date
For over half a century, millions of Americans living with heart disease have relied on a daily dose of aspirin to help prevent a heart attack or stroke. The large-scale ADAPTABLE study used Medidata solutions to manage patients virtually.